India Drug-Pricing Agency Rejects Appeals Of Three Drug Makers
This article was originally published in PharmAsia News
Executive Summary
India's drug-pricing regulator rejected the appeals of Abbott Healthcare, Alembic Pharmaceuticals and Dr. Reddy's Laboratories of previously set price caps on their drugs.